F. Hoffmann La Roche AG

news

R&D and tech innovation boosting biopharmaceutical market to 2030

2 June 2025 | By Catherine Eckford (European Pharmaceutical Review)

Advanced technology innovation is driving lower R&D costs and progress of targeted treatments such as cell and gene therapies, the research reports.

news

Innovating small molecule injectables: market forecast to 2033

5 June 2024 | By Catherine Eckford (European Pharmaceutical Review)

Key trends in the global small molecule injectable drugs market up to 2033 include advancements in technology, drug delivery systems and fast-track approvals of new drug formulations, research predicts.

article

Endotoxin testing: the international regulatory landscape

2 April 2024 | By Carmen Marín Delgado de Robles (Roche Basel-Kaiseraugst), Dr Lindsey Silva (Genentech), Evelyn Der (Genentech)

In this extract from EPR’s Pharma Horizon’s report, Evelyn Der, Lindsey Silva and Carmen Marín Delgado de Robles from Roche Group discuss the regulatory guidelines for bacterial endotoxin testing and the move towards adoption of recombinant methods.

news

Alzheimer’s therapeutics market to reach $6.8 billion by 2032

16 December 2022 | By Catherine Eckford (European Pharmaceutical Review)

A large patient population and limited treatment options are expected to expand the Alzheimer’s therapeutics market at a CAGR of 9.3 percent, suggested a report.